Robert F. Kennedy Jr. remains HHS Secretary following his February 2025 Senate confirmation, actively overseeing agency restructuring, budget proposals, and policy shifts on vaccines, chronic disease, and research funding into mid-2026. Congressional testimony and public statements from the administration show continued alignment with White House priorities, despite staff departures, external calls for removal, and partisan scrutiny over agency leadership changes. No formal resignation, dismissal proceedings, or term-limit triggers have emerged. Traders price the "No" outcome at 66.5% on expectations that institutional support and the absence of decisive political pressure will sustain his role through year-end, consistent with patterns for cabinet officials backed by the sitting president.